Potential use of gene transfer in athletic performance enhancement. (Q36902844)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

review article

1 reference

title

Potential use of gene transfer in athletic performance enhancement (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Anna Baoutina

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

John E J Rasko

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kerry R Emslie

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

7 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1751-1766

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680029%20AND%20SRC:MED&resulttype=core&format=json

Gene doping in sports: the science and ethics of genetically modified athletes

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

1 reference

7 January 2021

Rethinking enhancement in sport.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Doping in the recombinant era: strategies and counterstrategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Knocking down disease with siRNAs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

The potential of oligonucleotides for therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Engineering zinc finger protein transcription factors: the therapeutic relevance of switching endogenous gene expression on or off at command

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Induced dystrophin exon skipping in human muscle explants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Electroporation for gene transfer to skeletal muscles: current status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Electric pulse-mediated gene delivery to various animal tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Long-term regulated expression of growth hormone in mice after intramuscular gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Biology of E1-deleted adenovirus vectors in nonhuman primate muscle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Tissue engineering skeletal muscle for orthopaedic applications.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Gene-based therapeutic angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Non-viral vectors for gene therapy: clinical trials in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Hydrodynamic delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Gene transfer for hemophilia: can therapeutic efficacy in large animals be safely translated to patients?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Promoters and control elements: designing expression cassettes for gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Controlling the kinetics of transgene expression by plasmid design

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Gene therapy for severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Cancer gene-therapy: clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Autoimmune anemia in macaques following erythropoietin gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Erythropoietin gene therapy leads to autoimmune anemia in macaques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Erythropoietin as an angiogenic factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Inducible production of erythropoietin using intramuscular injection of block copolymer/DNA formulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Lentivectors for regulated and reversible cutaneous gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Adipose tissue as a novel target for in vivo gene transfer by adeno-associated viral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Drugs for increasing oxygen and their potential use in doping: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Human erythropoietin gene therapy for patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Long-term erythropoietin gene expression from transduced cells in bioisolator devices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Metabolic control through the PGC-1 family of transcription coactivators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Regulation of muscle fiber type and running endurance by PPARdelta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Organization of myocardial activation during ventricular fibrillation after myocardial infarction: evidence for sustained high-frequency sources.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Developmental endothelial locus-1 (Del-1), a novel angiogenic protein: its role in ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

IGF-I gene transfer by electroporation promotes regeneration in a muscle injury model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Mechanical signals, IGF-I gene splicing, and muscle adaptation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Muscle regeneration through myostatin inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Regulation of muscle mass by myostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Transcriptional profiling of myostatin-knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Postnatal expression of myostatin propeptide cDNA maintained high muscle growth and normal adipose tissue mass in transgenic mice fed a high-fat diet.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Effect of maternal myostatin antibody on offspring growth performance and body composition in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Induction of cachexia in mice by systemically administered myostatin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Regulation of myostatin activity and muscle growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Expression of the TGF-beta family of ligands is developmentally regulated in skeletal muscle of neonatal rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Multiple defects and perinatal death in mice deficient in follistatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

The induction of skeletal muscle hypertrophy by a ski transgene is promoter-dependent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Regulation of muscle growth by multiple ligands signaling through activin type II receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Myostatin gene silenced by RNAi show a zebrafish giant phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Effects of an alleged myostatin-binding supplement and heavy resistance training on serum myostatin, muscle strength and mass, and body composition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Effects of heavy resistance training on myostatin mRNA and protein expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Postexercise Myostatin and Activin IIb mRNA Levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Lack of myostatin results in excessive muscle growth but impaired force generation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Growth hormone isoforms and segments/fragments: molecular structure and laboratory measurement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Problems with GH doping in sports

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month’s treatment with supraphysiological doses of growth hormone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Glucocorticoid-regulated expression of exogenous human growth hormone gene in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

High-level secretion of growth hormone by retrovirally transduced primary human keratinocytes: prospects for an animal model of cutaneous gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Skeletal muscle as an artificial endocrine tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Growth hormone releasing hormone plasmid supplementation, a potential treatment for cancer cachexia, does not increase tumor growth in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

The potential of gene therapy for fracture healing in osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Delivery of growth factors using gene therapy to enhance bone healing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Effect of BMP-2 gene transfer on bone healing in sheep

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Gene transfer approaches to the healing of bone and cartilage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Gene therapy for cartilage defects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Direct adenovirus-mediated IGF-I gene transduction of synovium induces persisting synovial fluid IGF-I ligand elevations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Enhanced repair of the anterior cruciate ligament by in situ gene transfer: evaluation in an in vitro model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Menisci are efficiently transduced by recombinant adeno-associated virus vectors in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Gene therapy and tissue engineering for sports medicine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Gene transfer to human joints: progress toward a gene therapy of arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Gene gun particle encoding preproenkephalin cDNA produces analgesia against capsaicin-induced bladder pain in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Development of HSV-mediated gene transfer for the treatment of chronic pain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

DREAM is a critical transcriptional repressor for pain modulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

No DREAM, No pain. Closing the spinal gate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Genes and human elite athletic performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

No association between Angiotensin Converting Enzyme (ACE) gene variation and endurance athlete status in Kenyans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021

Activin-type II receptor B (ACVR2B) and follistatin haplotype associations with muscle mass and strength in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300278

7 January 2021